BioNTech SE

BNTX:NASDAQ
RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 9:17 AM EST
104.60quote price arrow down-0.83 (-0.79%)
Volume
19,761
Close
105.43quote price arrow up+2.20 (+2.13%)
Volume
2,236,512
52 week range
28.00 - 131.00

...

Loading . . .

KEY STATS

  • Open104.00
  • Day High107.30
  • Day Low103.20
  • Prev Close105.43
  • 52 Week High131.00
  • 52 Week High Date12/11/20
  • 52 Week Low28.00
  • 52 Week Low Date03/12/20
  • Market Cap25,386.49M
  • Shares Out240.79M
  • 10 Day Average Volume2.81M
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change188.53

RATIOS/PROFITABILITY

  • EPS (TTM)-2.01
  • P/E (TTM)-52.54
  • Fwd P/E (NTM)10.32
  • EBITDA (MRQ)-103.17M
  • ROE (MRQ)-
  • Revenue (MRQ)161.56M
  • Gross Margin (MRQ)88.28%
  • Net Margin (MRQ)-85.07%
  • Debt To Equity (MRQ)33.50%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest BNTX News From Our Partners

QUOTE FINDER

Related Video

VIDEO2:5202:52
What new Covid strains mean for available vaccines and treatments

Profile

MORE
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. It develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company...
Address
An der Goldgrube 12
Mainz
55131
Germany